More than 40 million HIV-infected people live in the developing world, yet it is estimated that only one in ten persons infected with HIV has been tested and knows his/her HIV status1. The U.S National Intelligence Council (NIC) predicted that the number of HIV-infected individuals in the developing world will rise to 80 million by 20102. Effective antiretroviral therapy (ART) for HIV has been available in developed countries for more than a decade. However, worldwide, less than 10% (1.3 million) of the infected individuals currently receive treatment, since they live in developing countries. Part of the problem associated with existing ART delivery systems are the limitations of conventional methods to diagnose and monitor infected individuals living in rural poor communities. To increase access to HIV care and to improve treatment outcome requires development of low-cost diagnostic tools for developing countries3-6. We propose to develop a low-cost point-of-care HIV diagnostic tool for the developing world. At the interface between Harvard and MIT we have access to the necessary infrastructure. Moreover, the PI was recognized as one of the top 35 young innovators of the world for his work on HIV diagnostic microchips for Global Health. More than 40 million HIV-infected people live in the developing world, yet it is estimated that only one in ten persons infected with HIV has been tested and knows his/her HIV status1 and we propose to develop a low-cost point-of-care HIV diagnostic tool for the developing world.

Public Health Relevance

More than 40 million HIV-infected people live in the developing world, yet it is estimated that only one in ten persons infected with HIV has been tested and knows his/her HIV status1 and we propose to develop a low-cost point-of-care HIV diagnostic tool for the developing world.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI081534-04
Application #
8220709
Study Section
Special Emphasis Panel (ZRG1-AARR-E (16))
Program Officer
Livnat, Daniella
Project Start
2009-03-03
Project End
2014-02-28
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
4
Fiscal Year
2012
Total Cost
$437,370
Indirect Cost
$192,345
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Wang, ShuQi; Chinnasamy, Thiruppathiraja; Lifson, Mark A et al. (2016) Flexible Substrate-Based Devices for Point-of-Care Diagnostics. Trends Biotechnol 34:909-921
Asghar, Waseem; Yuksekkaya, Mehmet; Shafiee, Hadi et al. (2016) Engineering long shelf life multi-layer biologically active surfaces on microfluidic devices for point of care applications. Sci Rep 6:21163
Shafiee, Hadi; Wang, ShuQi; Inci, Fatih et al. (2015) Emerging technologies for point-of-care management of HIV infection. Annu Rev Med 66:387-405
Inci, Fatih; Filippini, Chiara; Baday, Murat et al. (2015) Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics. Proc Natl Acad Sci U S A 112:E4354-63
Tokel, Onur; Yildiz, Umit Hakan; Inci, Fatih et al. (2015) Portable microfluidic integrated plasmonic platform for pathogen detection. Sci Rep 5:9152
Shafiee, Hadi; Kanakasabapathy, Manoj Kumar; Juillard, Franceline et al. (2015) Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva. Sci Rep 5:9919
Bajaj, Piyush; Schweller, Ryan M; Khademhosseini, Ali et al. (2014) 3D biofabrication strategies for tissue engineering and regenerative medicine. Annu Rev Biomed Eng 16:247-76
Bertassoni, Luiz E; Cecconi, Martina; Manoharan, Vijayan et al. (2014) Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip 14:2202-11
Shafiee, Hadi; Lidstone, Erich A; Jahangir, Muntasir et al. (2014) Nanostructured optical photonic crystal biosensor for HIV viral load measurement. Sci Rep 4:4116
Tokel, Onur; Inci, Fatih; Demirci, Utkan (2014) Advances in plasmonic technologies for point of care applications. Chem Rev 114:5728-52

Showing the most recent 10 out of 46 publications